Congenital Hyperinsulinism clinical trials at UCSF

1 research study open to eligible people

18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism
open to eligible people ages up to 18 years
The goal of this project is to determine the role of FDOPA/PET as a pre-operative diagnostic imaging procedure for differentiating focal and diffuse forms of congenital hyperinsulinism and locating focal lesions in the pancreas to guide surgical resection.
San Francisco, California

Last updated: May 16, 2022